Bioceres Crop Solutions (BIOX) Common Equity (2016 - 2026)

Bioceres Crop Solutions has disclosed Common Equity across 11 years of filings, most recently posting $95.7 million for Q1 2026.

• Common Equity for Q1 2026 came in at $95.7 million, down 72.26% year-over-year; the trailing twelve-month figure through Mar 2026 was $95.7 million (down 72.26% YoY), and the FY2025 annual result was $295.2 million, down 15.99% from the prior year.
• Common Equity came in at $95.7 million for Q1 2026 at Bioceres Crop Solutions, down from $106.6 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $351.4 million in Q2 2024 to a low of -$365.0 million in Q1 2022.
• The 5-year median for Common Equity is $330.5 million (2023), against an average of $251.2 million.
• Across the five-year window, Common Equity soared 221.75% in 2022 and tumbled 72.26% in 2026, its largest moves.
• Bioceres Crop Solutions' Common Equity stood at $306.6 million in 2022, then advanced by 9.34% to $335.3 million in 2023, then increased by 3.3% to $346.3 million in 2024, then sank by 69.22% to $106.6 million in 2025, then fell by 10.24% to $95.7 million in 2026.
• The last three Common Equity figures came in at $95.7 million (Q1 2026), $106.6 million (Q4 2025), and $288.3 million (Q3 2025), per Business Quant data.